Our firm leads investor diligence for private equity firms, venture capital firms, and strategic investors regarding hospital M&A, health plan M&A, and healthcare IT M&A transactions.
Representative Transactions
To date, we’ve been retained to assist on diligence related to over $4.9 billion in transactions in
- international Classification of Diseases, version 10 (ICD-10) coding,
- claims processing,
- eligibility checks,
- revenue cycle management
- electronic health records,
- eDiscovery,
- HIPAA and HITECH Act electronic release of information (eROI),
- Medicare claims processing,
- genetic testing,
- electronic data interchange (EDI),
- HIPAA compliant secure text messaging,
- HITECH Act and HIPAA compliant provider to provider communications,
- cloud computing,
- enterprise access management,
- single sign on,
- value based care (ACO),
- value based care (Medicare Advantage / Medicare Part C),
- health insurance exchanges,
- health information exchanges,
- pharmacy benefit management (PBM) and ePrescribing,
- clinical data analytics
- clinical decision support
- patient engagement
- acquisitions of provider organizations (hospitals and physician groups, IPAs)
- acquisitions of insurance firms
Representative Clients
- $1 billion fund managed by New York private equity firm
- $2 billion fund managed by London private equity firm with San Francisco office
- Top 3 Silicon Valley venture capital firm